These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 24061211

  • 1. Efficacy and tolerability of benzodiazepines versus antidepressants in anxiety disorders: a systematic review and meta-analysis.
    Offidani E, Guidi J, Tomba E, Fava GA.
    Psychother Psychosom; 2013; 82(6):355-62. PubMed ID: 24061211
    [Abstract] [Full Text] [Related]

  • 2. A major change of prescribing pattern in absence of adequate evidence: benzodiazepines versus newer antidepressants in anxiety disorders.
    Berney P, Halperin D, Tango R, Daeniker-Dayer I, Schulz P.
    Psychopharmacol Bull; 2008; 41(3):39-47. PubMed ID: 18779775
    [Abstract] [Full Text] [Related]

  • 3. Should benzodiazepines be replaced by antidepressants in the treatment of anxiety disorders? Fact or fiction?
    Rickels K.
    Psychother Psychosom; 2013; 82(6):351-2. PubMed ID: 24061092
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Benzodiazepines as a Monotherapy in Depressive Disorders: A Systematic Review.
    Benasi G, Guidi J, Offidani E, Balon R, Rickels K, Fava GA.
    Psychother Psychosom; 2018; 87(2):65-74. PubMed ID: 29466801
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparative efficacy of antidepressants in preventing relapse in anxiety disorders - a meta-analysis.
    Donovan MR, Glue P, Kolluri S, Emir B.
    J Affect Disord; 2010 Jun; 123(1-3):9-16. PubMed ID: 19616306
    [Abstract] [Full Text] [Related]

  • 9. Meta-analysis of the comparative efficacy of benzodiazepines and antidepressants for psychic versus somatic symptoms of generalized anxiety disorder.
    Beyer C, Currin CB, Williams T, Stein DJ.
    Compr Psychiatry; 2024 Jul; 132():152479. PubMed ID: 38564872
    [Abstract] [Full Text] [Related]

  • 10. Antidepressant drugs in anxiety disorders.
    Modigh K.
    Acta Psychiatr Scand Suppl; 1987 Jul; 335():57-74. PubMed ID: 3314359
    [Abstract] [Full Text] [Related]

  • 11. The pharmacologic treatment of anxiety disorders: a review of progress.
    Ravindran LN, Stein MB.
    J Clin Psychiatry; 2010 Jul; 71(7):839-54. PubMed ID: 20667290
    [Abstract] [Full Text] [Related]

  • 12. Pharmacotherapy of generalized anxiety disorder.
    Davidson JR.
    J Clin Psychiatry; 2001 Jul; 62 Suppl 11():46-50; discussion 51-2. PubMed ID: 11414551
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pharmacologic treatments effective in both generalized anxiety disorder and major depressive disorder: clinical and theoretical implications.
    Casacalenda N, Boulenger JP.
    Can J Psychiatry; 1998 Sep; 43(7):722-30. PubMed ID: 9773222
    [Abstract] [Full Text] [Related]

  • 15. Antidepressants for generalized anxiety disorder.
    Kapczinski F, Lima MS, Souza JS, Schmitt R.
    Cochrane Database Syst Rev; 2003 Sep; (2):CD003592. PubMed ID: 12804478
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Risk of relapse after antidepressant discontinuation in anxiety disorders, obsessive-compulsive disorder, and post-traumatic stress disorder: systematic review and meta-analysis of relapse prevention trials.
    Batelaan NM, Bosman RC, Muntingh A, Scholten WD, Huijbregts KM, van Balkom AJLM.
    BMJ; 2017 Sep 13; 358():j3927. PubMed ID: 28903922
    [Abstract] [Full Text] [Related]

  • 18. Benzodiazepines in generalized anxiety disorder: heterogeneity of outcomes based on a systematic review and meta-analysis of clinical trials.
    Martin JL, Sainz-Pardo M, Furukawa TA, Martín-Sánchez E, Seoane T, Galán C.
    J Psychopharmacol; 2007 Sep 13; 21(7):774-82. PubMed ID: 17881433
    [Abstract] [Full Text] [Related]

  • 19. D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic Stress Disorders: A Systematic Review and Meta-analysis of Individual Participant Data.
    Mataix-Cols D, Fernández de la Cruz L, Monzani B, Rosenfield D, Andersson E, Pérez-Vigil A, Frumento P, de Kleine RA, Difede J, Dunlop BW, Farrell LJ, Geller D, Gerardi M, Guastella AJ, Hofmann SG, Hendriks GJ, Kushner MG, Lee FS, Lenze EJ, Levinson CA, McConnell H, Otto MW, Plag J, Pollack MH, Ressler KJ, Rodebaugh TL, Rothbaum BO, Scheeringa MS, Siewert-Siegmund A, Smits JAJ, Storch EA, Ströhle A, Tart CD, Tolin DF, van Minnen A, Waters AM, Weems CF, Wilhelm S, Wyka K, Davis M, Rück C, the DCS Anxiety Consortium, Altemus M, Anderson P, Cukor J, Finck C, Geffken GR, Golfels F, Goodman WK, Gutner C, Heyman I, Jovanovic T, Lewin AB, McNamara JP, Murphy TK, Norrholm S, Thuras P.
    JAMA Psychiatry; 2017 May 01; 74(5):501-510. PubMed ID: 28122091
    [Abstract] [Full Text] [Related]

  • 20. The efficacy and safety of drug treatments for chronic insomnia in adults: a meta-analysis of RCTs.
    Buscemi N, Vandermeer B, Friesen C, Bialy L, Tubman M, Ospina M, Klassen TP, Witmans M.
    J Gen Intern Med; 2007 Sep 01; 22(9):1335-50. PubMed ID: 17619935
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.